Neoadjuvant chemotherapy in elderly women with ovarian cancer: rates of use and effectiveness

BACKGROUND: Neoadjuvant chemotherapy (NACT) may reduce perioperative morbidity in women undergoing primary treatment for ovarian cancer. We evaluated patterns of use and outcomes in a population-based cohort of elderly women with ovarian cancer (OC). METHODS: A cohort of patients ≥66 years old diagn...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gynecol Oncol
Egile Nagusiak: Meyer, Larissa A, He, Weiguo, Sun, Charlotte C, Zhao, Hui, Wright, Alexi A, Suidan, Rudy S, Dottino, Joseph, Rauh-Hain, J. Alejandro, Lu, Karen H, Giordano, Sharon H
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8328050/
https://ncbi.nlm.nih.gov/pubmed/29961559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.06.020
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak